Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$11,335,189
+$408,233 QoQ
Shares Held
44,632
-0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
4.61%
of 13F equity value
Holder Rank
#1,037
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN STRUM & TOWNE INC. holds $44,052,208 across 8 Drug Manufacturers - General names. JNJ ranks #1 (25.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
44,632 | $11,335,189 | |
| 2 | AMGN |
Amgen Inc
|
31,250 | $11,316,250 | |
| 3 | ABBV |
AbbVie Inc.
|
37,773 | $9,505,197 | |
| 4 | LLY |
ELI LILLY & Co
|
5,679 | $6,811,563 | |
| 5 | PFE |
Pfizer Inc
|
85,044 | $2,047,859 | |
| 6 | MRK |
Merck & Co., Inc.
|
13,293 | $1,708,150 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,392 | $944,507 | |
| 8 | NVS |
Novartis AG
|
2,447 | $383,493 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,335,189 | 44,632 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $10,926,956 | 44,702 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $9,309,024 | 44,982 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $8,339,635 | 44,977 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $6,981,744 | 45,707 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $7,876,902 | 47,497 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $6,626,054 | 45,817 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $7,414,569 | 45,752 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,695,881 | 45,812 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $7,300,784 | 46,152 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $7,286,372 | 46,487 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $7,377,410 | 47,367 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,749,149 | 46,817 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $7,374,435 | 47,577 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,387,695 | 47,482 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $7,763,193 | 47,522 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,479,830 | 47,771 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,431,185 | 47,572 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $8,026,946 | 46,922 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $7,272,668 | 45,032 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,410,334 | 44,982 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $7,571,111 | 46,067 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $7,122,546 | 45,257 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $6,560,992 | 44,069 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,098,982 | 43,369 | Shares | Defined | 2020-07-14 | |
| 2020-03-31 | $5,719,103 | 43,614 | Shares | Defined | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||